More than 35 000 people die from antimicrobial-resistant infections in the EU/EEA each year, according to estimates presented in a new report released today. The estimated number of deaths in the report examines the years 2016-2020 and shows an increase from previous estimates. The health impact of antimicrobial resistance (AMR) is comparable to that of influenza, tuberculosis and HIV/AIDS combined.
Version 6.1 is the final protocol for the third EU-wide point prevalence survey in acute care hospitals (PPS 2022–2023). It contains important changes compared to protocol version 5.3 (PPS 2016–2017), including on healthcare-associated COVID-19.
Anthrax continues to be a rare disease in humans in Europe, with only a few cases reported every year. For 2017, two European Union/European Economic Area (EU/EEA) countries reported six confirmed anthrax cases (Romania reported five cases and Bulgaria one). The remaining 28 reporting countries did not notify any confirmed cases.
Anthrax continues to be an uncommon disease in humans in Europe, with only a few cases reported every year. For 2018, three confirmed anthrax cases were reported, one each in Netherlands, Romania and Spain. Twenty-seven EU/EEA countries notified zero confirmed cases.